Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1386996

registered interest
date	10/12/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Vaccine Manufacturing and Innovation Centre
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, for what reason the Government is selling the Vaccine Manufacturing and Innovation Centre.
tabling member constituency	North Tyneside
tabling member printed	Mary Glindon
uin	90873
answer	answer is ministerial correction date of answer 16/12/2021 answer text <p>VMIC was a project set up in the 2017 Life Sciences Sector Deal to support UK leadership in next generation vaccine manufacturing technology. The pandemic has dramatically accelerated both the demand and the technology of vaccine production since VMIC was established. The Government has invested over £380 million to secure and scale-up the UK’s manufacturing capabilities to be able to respond to this pandemic, as well as any future pandemics, and in support of vaccine innovation at numerous facilities across the UK. Our positive engagement with industry and the UK’s strong science base and international reputation has also seen a number of private investments across the whole of the UK announced over the past year. These include Serum Institute of India’s £50m investment into Oxford Biomedica, Thermo Fisher Scientific’s £70m expansion of its Swindon site and Fujifilm’s £400m investment into its Billingham, Teesside facility.</p><p>One such facility that the Government provided support to is the Vaccine Manufacturing Innovation Centre (VMIC) which has the potential to be a significant part of the UK vaccine manufacturing ecosystem. VMIC is a private company, limited by guarantee, and as such the UK Government does not exercise any ownership rights.</p><p>Officials are working closely with VMIC and other third parties to ensure that the UK retains a strong domestic vaccine manufacturing capability to contribute to our response to COVID-19 and resilience to other future health emergencies. We will ensure that the UK’s vaccine capabilities continue to benefit from the public investment. Discussions are commercially sensitive between VMIC and private potential acquirers.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 16/12/2021 10:16:16 answering member 4020 label Biography information for George Freeman previous answer version 39501 answering member constituency Mid Norfolk answering member printed George Freeman answering member 4020 label Biography information for George Freeman
tabling member	4126 label Biography information for Mary Glindon

353919

registered interest
date	12/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Stem Cells: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to support scientific research into stem cell transplantation.
tabling member constituency	North Tyneside
tabling member printed	Mary Glindon
uin	2328
answer	answer is ministerial correction date of answer 19/06/2015 answer text <p>A wide range of research relating to stem cell transplantation is supported by the Department through the National Institute for Health Research (NIHR). The translation of scientific advances to the clinic is supported through NIHR Biomedical Research Centres and Units, clinical research facilities and experimental cancer medicine centres (funded jointly with Cancer Research UK). The NIHR clinical research network supports the coordination of clinical trials including any involving stem cell transplantation. NHS Blood and Transplant are directly involved in a number of research projects and provide an essential part of the necessary infrastructure supporting research in this field. NHS England supports the important role of innovation and research in transforming the quality of services.</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 19/06/2015 11:09:08 answering member 4020 label Biography information for George Freeman
tabling member	4126 label Biography information for Mary Glindon

353920

registered interest
date	12/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS England: Public Consultation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when he expects NHS England to respond to its consultation on Investing in Specialised Services.
tabling member constituency	North Tyneside
tabling member printed	Mary Glindon
uin	2329
answer	answer is ministerial correction date of answer 19/06/2015 answer text <p>NHS England expects to publish its response to the Investing in Specialised Services consultation by the end of June 2015.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 19/06/2015 10:58:35 answering member 4020 label Biography information for George Freeman
tabling member	4126 label Biography information for Mary Glindon

348294

registered interest
date	03/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Co-careldopa
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many submissions NHS England has received on the consultation on Duodopa levodopa-carbidopa intestinal gel clinical commissioning policy.
tabling member constituency	North Tyneside
tabling member printed	Mary Glindon
uin	980
answer	answer is ministerial correction date of answer 12/06/2015 answer text <p>NHS England has advised that there were 35 online responses received during the 30 day consultation period.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 12/06/2015 10:52:01 answering member 4020 label Biography information for George Freeman
tabling member	4126 label Biography information for Mary Glindon